Regeneron Pharmaceuticals, Inc.

CULLEN/FROST BANKERS, INC. REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/6/2026

Shares

430

Value ($000)

332

Weight

0.0%

2019 Q4 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/6/2026	332	0.0%	430	12/31/2025
2025 Q3	10/31/2025	292	0.0%	519	9/30/2025
2025 Q2	7/30/2025	3,372	0.0%	6,423	6/30/2025
2025 Q1	5/2/2025	4,356	0.1%	6,868	3/31/2025
2024 Q4	2/6/2025	4,493	0.1%	6,307	12/31/2024
2024 Q3	11/6/2024	493	0.0%	469	9/30/2024
2024 Q2	8/5/2024	449	0.0%	427	6/30/2024
2024 Q1	5/10/2024	314	0.0%	326	3/31/2024
2023 Q4	2/6/2024	278	0.0%	317	12/31/2023
2023 Q3	11/2/2023	277	0.0%	337	9/30/2023
2023 Q2	8/4/2023	206	0.0%	287	6/30/2023
2023 Q1	5/5/2023	269	0.0%	327	3/31/2023
2022 Q4	2/13/2023	236	0.0%	327	12/31/2022
2022 Q3	11/7/2022	247	0.0%	358	9/30/2022
2022 Q2	8/5/2022	175	0.0%	296	6/30/2022
2022 Q1	5/9/2022	210	0.0%	300	3/31/2022
2021 Q4	2/7/2022	189	0.0%	300	12/31/2021
2021 Q3	11/4/2021	179	0.0%	296	9/30/2021
2020 Q4	2/8/2021	72	0.0%	150	12/31/2020
2020 Q3	11/5/2020	149	0.0%	267	9/30/2020
2020 Q2	8/5/2020	156	0.0%	250	6/30/2020
2020 Q1	5/1/2020	49	0.0%	100	3/31/2020
2019 Q4	2/6/2020	38	0.0%	100	12/31/2019